| 1. |
Hata J, Ninomiya T, Epidemiology of stroke in a general Japanese population: the
Hisayama Study., Atheroscler Thromb , 30: 710-719, 2023, 2023.07. |
| 2. |
二宮利治, 認知症対策におけるコホート研究と予防について．久山町研究の知見より．, 第38回日本認知症学会学術集会モーニングセミナー1記録集: , 第38回日本認知症学会学術集会モーニングセミナー1記録集: 1-4, 2020, 2020.01. |
| 3. |
Ohara T, Ninomiya T, Reply to "Long sleep duration: An epiphenomenon or a risk for dementia?"., J Am Geriatr Soc 66: 2225-2226, 2018, 2018.11. |
| 4. |
Umehara K, Mukai N, Kitazono T, Hoka S, Kiyohara Y, Ninomiya T, Serum 1,25-Dihydroxyvitamin D level is inappropriate for use in prospective studies of cancer incidence - Reply., Circ J 82: 2216, 2018, 2018.07. |
| 5. |
Hata J, Yubi T, Ninomiya T, Author response: Prevalence of and risk factors for cerebral microbleeds in a general Japanese elderly community., Neurology: Clinical Practice, 2018.02. |
| 6. |
Ninomiya T, Japanese legacy cohort studies: the Hisayama Study., J Epidemiol , 28: 444-451, 2018, 2018.10. |
| 7. |
Kang A, Nigwekar SU, Perkovic V, Kulshrestha S, Zoungas S, Navaneethan SD, Cass A, Gallagher MP, Ninomiya T, Strippoli GF, Jardine M, Interventions for lowering plasma homocysteine levels in kidney transplant recipients., Cochrane Database Syst Rev 5, 2015.05. |
| 8. |
Ninomiya T, Patterns of Japanese Diet and Risk of Dementia, Curr Nutr Rep 4, 2015.04. |
| 9. |
Toyoda K, Ninomiya T, Stroke and cerebrovascular diseases in patients with chronic kidney disease, Lancet Neurol 13: 823-833, 2014, 2014.08. |
| 10. |
Ninomiya T, Diabetes mellitus and dementia, Curr Diab Rep 14: 487, 2014, 2014.01. |
| 11. |
Ninomiya T, Risk of stroke in kidney disease, Contrib Nephrol 179: 58-66, 2013, 2013.05. |
| 12. |
Shikata K, Ninomiya T, Kiyohara Y., Diabetes mellitus and cancer risk: Review of the epidemiological evidence, Cancer Sci 104: 9-14, 2013, 2013.02. |
| 13. |
Jun M, Venkataraman V, Razavian M, Cooper B, Zoungas S, Ninomiya T, Webster AC, Perkovic V, Antioxidants for chronic kidney disease, Cochrane Database Syst Rev, CD008176, 2012, 2012.12. |
| 14. |
Ninomiya T, Hypertension in the older patient: practical clinical management., Clinical Medicine Reviews in Vascular Health 4: 29-42, 2012, 2012.04. |
| 15. |
Ninomiya T, Is metabolic syndrome a risk factor for cardiovascular disease in late elderly?, Am J Hypertens 24: 1193, 2011, 2011.05. |
| 16. |
[No author list]., Albuminuria and eGFR predict cardiovascular and renal risk., Nature Review Nephrology 5: 606, 2009, 2009.11. |
| 17. |
Ninomiya T, Perkovic V., Routine administration of a fixed combination of perindopril-indapamide reduced the risk of kidney events in diabetes., AUANews 2009, 2009.06. |
| 18. |
Chalmers J, Joshi R, Kengne AP, Ninomiya T, Bi Y, Bompoint S, Billot L, Patel A; ADVANCE Collaborative Group., Efficacy and safety of fixed combination of perindopril and indapamide in type 2 diabetes: results from ADVANCE in context of available evidence, J Hypertens 26 Suppl 3: S21-S27, 2008, 2008.09. |
| 19. |
[No author list]., Low blood pressure does protect against stroke in CKD., Nature Clinical Practice Nephrology 4: 291, 2008, 2008.06. |
| 20. |
Ninomiya T, Kiyohara Y., Albuminuria and chronic kidney disease in association with the metabolic syndrome., J Cardiometab Syndr 2: 104-107, 2007, 2007.02. |
